![](https://www.discoverx.com/content/uploads/2023/05/Assay-Kits_Small-Card-Image-310x174.jpg)
Ready-to-use kits for early discovery phases for screening, proof-of-concept, MOA confirmation, or rank-ordering studies
Read MoreShowing 13–24 of 39 results
Ready-to-use kits for early discovery phases for screening, proof-of-concept, MOA confirmation, or rank-ordering studies
Read MoreAccurately monitor GPCR activation by biologics or small molecules & detect cellular cAMP production levels for a variety of applications
Read MoreNon-imaging, cell-based internalization assays for screening & identifying safer drugs for GPCRs
Read MoreUniversal G-protein independent cell-based assays to quantify GPCR activation based on the recruitment of β-arrestin
Read MoreDirectly measure cellular cGMP when studying cGMP-dependent phosphodiesterases & cGMP signaling receptors
Read MoreReady-to-use, cell-based bioassay kits to measure direct cell death for screening, characterization, & potency testing
Read MoreSingle donor-derived human primary cells to drive robust & reproducible ADCC & T-cell redirection
Read MoreCell-based assays to evaluate activation & translocation of nuclear proteins including nuclear hormone receptors
Read MoreAssays to interrogate the MOA of GLP-1, GIP, and GCG receptors targeting therapeutics to accelerate obesity and type-2 diabetes drug…
Read MoreQuantitative cell-based assays to identify pharmacochaperones that stabilize & correct disease-relevant mutant GPCRs, ion channels, or transporters
Read MoreProviding functional, MOA-based bioassays with superior lot-to-lot reproducibility & potency testing
Read More